Inovio Pharmaceuticals, Inc.
(NASDAQ : INO)

( )
INO PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Loading INO News...
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
0.59%89.310.6%$403.50m
ABTAbbott Laboratories
-0.41%48.470.8%$368.49m
ISRGIntuitive Surgical, Inc.
1.10%946.317.5%$336.27m
BDXBecton, Dickinson and Company
0.01%195.011.3%$289.08m
ALGNAlign Technology, Inc.
1.94%152.246.2%$272.05m
BCRC. R. Bard, Inc.
-0.01%316.061.6%$251.10m
TMOThermo Fisher Scientific Inc.
1.17%175.741.0%$220.85m
BSXBoston Scientific Corporation
1.08%28.111.1%$217.28m
BAXBaxter International Inc.
0.30%60.871.7%$198.99m
SYKStryker Corporation
0.13%139.771.3%$159.20m
ZBHZimmer Biomet Holdings, Inc.
0.19%128.491.7%$136.89m
EWEdwards Lifesciences Corporation
1.09%118.411.2%$128.48m
COOCooper Companies, Inc.
-0.38%242.332.2%$116.16m
IDXXIDEXX Laboratories, Inc.
1.36%164.653.6%$115.54m
HOLXHologic, Inc.
0.64%45.781.6%$113.28m

Company Profile

Inovio Pharmaceuticals, Inc. is a bio pharmaceutical company. It develops active DNA immunotherapies for cancer and infectious diseases. The company's portfolio of immune therapies includes SynCon immunotherapies and electroporation delivery systems. Its pipeline consists vgx-3100, ino-3122, ino-3106, pennvax-b and pennvax-g. The company was founded on June 29, 1983 and is headquartered in Plymouth Meeting, PA.